The axial distribution of nicotine content along hair shaft as an indicator of changes in smoking behaviour: evaluation in a smoking‐ cessation programme with or without the aid of nicotine chewing gum.

British Journal of Clinical Pharmacology

Volumn 39, Issue 6, 1995, Pages 665-669

  Uematsu, T ^a   Mizuno, A ^a   Nagashima, S ^a   Oshima, A ^a   Nakamura, M ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ADULT; ARTICLE; CHEWING GUM; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DISTRIBUTION; EXPIRED AIR; FEMALE; GAS CHROMATOGRAPHY; HAIR; HAIR ANALYSIS; HUMAN; MALE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

ADULT; BREATH TESTS; CARBON MONOXIDE; CHEWING GUM; FEMALE; HAIR; HUMAN; MALE; MIDDLE AGE; NICOTINE; SMOKING CESSATION;

EID: 0029034696     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1995.tb05726.x     Document Type: Article

References (18)

1. The impact of the decreased prevalence of smoking in Canada
2. Actual causes of death in the United States
3. Smoking: its influence on survival and cause of death
4. Meta‐analytical review of the efficacy of nicotine chewing gum in smoking treatment programs
5. Clinical evaluation of nicotine resin complex as a smoking cessation aid: Double‐blind comparative study
6. How effective is nicotine replacement therapy in helping people to stop smoking?
7. Relationship between smoking status and serum lipids in a hyperlipidemic population and analysis of possible confounding factors
8. Therapeutic drug monitoring in hair samples: Principles and practice
9. Utilization of hair analysis for therapeutic drug monitoring with a special reference to ofloxacin and to nicotine
10. Drug analysis in hair samples and its clinical implications
11. Analysis of nicotine content of hair for assessing individual cigarette‐smoking behaviour
12. Low cost carbon monoxide monitors in smoking assessment
13. Analysis for nicotine and cotinine in hair to determine cigarette smoker status
14. Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment
15. Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair
16. Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol
17. Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis
18. Using ofloxacin as a time marker in hair analysis for monitoring dosage history of haloperidol